NextGen Biomed 2026

24 - 25 March 2026
QEII Centre, London, UK
QEII Centre, London, UK
Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.
Our Monthly Science Exchanges and Webinars keep you connected to the conversation.
NextGen Biomed is the platform to advance the fields of biologics, vaccines & novel therapeutics approaches, helping to deliver life-saving medicines to patients faster.
NextGen Biomed is committed to supporting R&D scientists, as well as drug development and manufacturing experts, working with biologics, peptides, and oligonucleotides to overcome complexities at every stage of the drug product lifecycle.
We work with leading journal publications on reciprocal marketing arrangements.
At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.
Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.
The latest in from nextgen biomed research & development
A carefully curated event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of novel immunotherapies; advances in cellular, antibody and combination therapy development as well as personalised cancer therapy treatments.
Hear from past attendees of the Biologics 2024 conference
Gain invaluable insights into advancing the discovery & development of immunotherapies to treat cancer & autoimmune diseases. Aligned with current industry trends, the 2026 programme will provide exclusive insights into cell-based therapeutics approaches, cytokine therapies and tolerization immunotherapies
Unlock the power of multi-omics approaches in immunotherapy. Thought-leaders will be discussing the utilization of spatial technologies in immunotherapy research, single cell sequencing & digital pathology for immune-oncology
Be at the forefront of nextgen targets & novel therapeutic strategies innovations. Hear about advancements in the discovery of best-in-class therapeutic antibodies, biomarker discovery & validation and the latest technological approaches
Take a deep dive into using translational models in immuno-oncology. Gain invaluable insights into in vivo and in vitro approaches, humanized & 3D mouse models and the role of the tumour microenvironment in ensuring clinical success
leading pharma, biotech, regulatory & academic delegates
Track 4: Cancer Vaccines & Personalised Cancer Therapies
Track 8: Discovery & Development Of Therapies For Cancer & Autoimmune Diseases
Track 9: Clinical Insights in Immuno-Oncology: Biomarkers, Pharmacokinetics & Safety Monitoring
Track 10: Next-Gen Targets & Therapeutic Strategies: Identification, Validation & Emerging Platforms
Track 8: Optimising Clinical Development: Efficacy, Safety & Combination Strategies
Track 9: Multi-Omics Approaches in Immunotherapy
Track 10: Translational Models in Immuno-Oncology: In Vitro & In Vivo Approaches
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.